TY - JOUR
T1 - The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination
AU - Visser, Gina D.
AU - Lill, Nancy L.
N1 - Funding Information:
We thank John Koland, Chuck Yeaman, Kathryn Stern, and Trent Place for helpful critiques of the work and manuscript, Satvir S. Tevethia for continuing support, and Jussara Hagen, Soumya Vemuganti, Justin Fishbaugh, and Gene Hess for technical assistance. The University of Iowa College of Medicine Core Research Facilities (Flow Cytometry, Crystallography, DNA, and Tissue Culture/Hybridoma facilities) provided resources utilized in these studies. The work was supported by the following awards to N.L.L.: American Cancer Society Research Scholar Grant RSG-03-046-01; and from the University of Iowa, a Biological Sciences Funding Program Award, a Carver College of Medicine Research Award, a developmental funding allocation from the NCI Cancer Center Support Grant P30-CA86862, and an individual allocation from the American Cancer Society Institutional Research Grant IRG-122-V (the latter two awards from the Holden Comprehensive Cancer Center).
PY - 2005/12/10
Y1 - 2005/12/10
N2 - Evolutionarily conserved sequences of the E3/protein-ubiquitin ligase Cbl regulate epidermal growth factor receptor (EGF-R) signaling and degradation. These sequences encompass Cbl's tyrosine kinase-binding domain, linker region, RING finger (RF), and an uncharacterized flank C-terminal to the RF (residues 420-436). The latter domain, designated the RF tail, extends beyond Cbl's ubiquitin-conjugating enzyme (Ubc)-binding domain and has no known function. We report structure-function studies evaluating the impact of Cbl RF tail truncations on EGF-R fate in HEK 293 cells. All of the truncation mutants exhibit greatly reduced binding to activated EGF-R and lack proline-rich sequences that mediate direct Cbl association with SH3 proteins such as Grb2, yet a subset of mutants collectively enhances EGF-R ubiquitination, downregulation, and degradation. Significantly, EGF-R degradation correlates better with RF tail-dependent degradation of the Cbl substrate Sprouty2 than with EGF-R ubiquitination: expression of the RF tail truncation mutant Cbl 1-433 enhanced EGF-R ubiquitination while impeding Sprouty2 degradation, and Cbl 1-433 failed to enhance EGF-R downregulation or degradation. Our results suggest that EGF-R fate is controlled by a checkpoint downstream of receptor ubiquitination whose regulation by the Cbl RF tail may require Sprouty2 degradation.
AB - Evolutionarily conserved sequences of the E3/protein-ubiquitin ligase Cbl regulate epidermal growth factor receptor (EGF-R) signaling and degradation. These sequences encompass Cbl's tyrosine kinase-binding domain, linker region, RING finger (RF), and an uncharacterized flank C-terminal to the RF (residues 420-436). The latter domain, designated the RF tail, extends beyond Cbl's ubiquitin-conjugating enzyme (Ubc)-binding domain and has no known function. We report structure-function studies evaluating the impact of Cbl RF tail truncations on EGF-R fate in HEK 293 cells. All of the truncation mutants exhibit greatly reduced binding to activated EGF-R and lack proline-rich sequences that mediate direct Cbl association with SH3 proteins such as Grb2, yet a subset of mutants collectively enhances EGF-R ubiquitination, downregulation, and degradation. Significantly, EGF-R degradation correlates better with RF tail-dependent degradation of the Cbl substrate Sprouty2 than with EGF-R ubiquitination: expression of the RF tail truncation mutant Cbl 1-433 enhanced EGF-R ubiquitination while impeding Sprouty2 degradation, and Cbl 1-433 failed to enhance EGF-R downregulation or degradation. Our results suggest that EGF-R fate is controlled by a checkpoint downstream of receptor ubiquitination whose regulation by the Cbl RF tail may require Sprouty2 degradation.
UR - http://www.scopus.com/inward/record.url?scp=27744568732&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27744568732&partnerID=8YFLogxK
U2 - 10.1016/j.yexcr.2005.09.015
DO - 10.1016/j.yexcr.2005.09.015
M3 - Article
C2 - 16246327
AN - SCOPUS:27744568732
SN - 0014-4827
VL - 311
SP - 281
EP - 293
JO - Experimental Cell Research
JF - Experimental Cell Research
IS - 2
ER -